CN110959720A

CN110959720A - Blood fat reducing herbal tea composition

Info

Publication number: CN110959720A
Application number: CN201911351551.1A
Authority: CN
Inventors: 吴宏图; 陈斌; 王彬帆
Original assignee: Hangzhou Xinhe Health Management Co Ltd
Current assignee: Hangzhou Xinhe Health Management Co Ltd
Priority date: 2019-12-25
Filing date: 2019-12-25
Publication date: 2020-04-07

Abstract

The invention belongs to the field of health-care food, and particularly relates to a herbal tea composition with a blood fat reducing effect, which consists of wintersweet leaves, small black tea and cyclocarya paliurus, and is prepared from the following raw materials in parts by weight: 2-3 parts of wintersweet leaves, 2-3 parts of millet black tea and 1-2 parts of cyclocarya paliurus. The blood fat reducing herbal tea composition provided by the invention has no toxic or side effect, has good effects of reducing triglyceride and cholesterol, and can improve the concentration of high-density lipoprotein, thereby reducing the incidence rate of other diseases caused by hyperlipidemia.

Description

Blood fat reducing herbal tea composition

Technical Field

The invention belongs to the field of health-care food, and particularly relates to an edible herbal tea composition with a blood fat reducing effect.

Background

Blood lipids are a general term for neutral fats (triglycerides) and lipids (phospholipids, glycolipids, sterols, steroids) in plasma, and are widely present in the human body. They are essential substances for the basal metabolism of living cells. Generally, the main components in blood lipids are triglycerides, which are involved in energy metabolism in the human body, and cholesterol, which is mainly used for the synthesis of cell plasma membranes, steroid hormones, and bile acids.

Blood lipid tends to be in a stable state under normal conditions, but the blood lipid level is easily affected by non-disease factors, so that the blood lipid is increased to become high blood lipid. The greatest risk of hyperlipidemia is mainly atherosclerosis, which induces atherogenic cardiovascular disease. The symptoms usually manifest as: dizziness, lassitude, insomnia, amnesia, numbness of the limbs, chest distress, palpitation, etc., often accompanied by overweight and obesity. The serious patients can cause facial distortion and speech failure, and finally can cause serious diseases such as coronary heart disease, cerebral apoplexy, fatty liver, liver cirrhosis and the like. These all can seriously affect the quality of life and place a significant burden on society and families.

In the prior art, the common drug for reducing triglyceride is fenofibrate, and the common drug for reducing cholesterol is statin (such as simvastatin and atorvastatin). However, the long-term taking of the drugs can generate obvious side effects on the body, wherein the main side effects of fenofibrate are gastrointestinal discomfort, rash, hyposexuality, insomnia and other symptoms, and the main side effect of statins is liver damage, which affects the body health to a certain extent.

Common tea is prepared by processing stems and leaves of Theaceae plants as raw materials, such as green tea, brick tea, oolong tea and the like, and has the effects of clearing heat, quenching thirst, relieving summer heat and refreshing, and does not pay attention to the effect of reducing blood fat.

The herbal tea is also named as cold food, cold green food, cold chang food and trabecular strut food, has cold nature and slightly bitter and pungent taste, and enters the channels of the lung, spleen and stomach. It can be used for treating hyperlipidemia, obesity, dyspepsia, abdominal distention, diarrhea, etc., and has good therapeutic effect and fragrant volatile oil fragrance, and can be used for treating cold-dampness affecting spleen, incoordination between liver and stomach, and digestive dysfunction.

The she-herb tea is the most widely used she medicine by the masses in the Lishu area of Zhejiang province, is reputed to be the first she medicine, is commonly called Xiangfeng tea and Maoshan tea in Anhui and Jiangxi, is called Huangjin tea in Zhejiang Kaihua, and Lishu is called Shi-herb tea, is a medicine-food dual-purpose special medicinal material commonly used by the masses in Han nationality in the area, has the effects of clearing heat and removing toxicity, invigorating stomach and promoting digestion, and is mainly used for treating cold, digestive tract diseases and the like in folk and clinic. The herb tea is prepared from Chimonanthus salicifolius (Chimonanthus salicifolius S.Y.Hu) or Zhejiang wax plum (Chimonanthus zhejiangensis M.C.Liu) of Chimonanthus in Chimonanthus of Chimonanthus in 2015 edition.

She nationality is mainly used for treating fullness caused by overeating, chronic gastritis, gastrectasia, stomachache, pantothenic acid and the like caused by gastric and duodenal ulcer, and also for preventing and treating cold and influenza. Modern researches show that the active ingredients of the herbal tea also comprise nonvolatile ingredients such as flavone, coumarin and anthraquinone besides the volatile oil, wherein the flavonoid ingredients are taken as main ingredients, and the flavonoid substances have pharmacological actions such as anti-inflammation, antibiosis, antivirus and antitumor.

The prior herbal tea-eating document mainly focuses on the treatment of enteritis, stomach diseases and the like by taking herbal tea as food, for example, Chinese invention with the publication number of CN1931200A, and also provides a medicinal food containing wintersweet as a patent of Chinese invention with the publication number of CN102308898A, which is characterized by comprising the following components, by weight, 78-94% of wintersweet, 1-8% of tuckahoe, 4-15% of red peony root, 0.2-2.5% of chrysanthemum and 0-1.5% of schizonepeta spike.

Disclosure of Invention

Aiming at the defects and shortcomings of the prior art, the invention aims to provide the blood fat reducing tea without toxic or side effect, which has good effects of reducing triglyceride and cholesterol and can improve the concentration of high-density lipoprotein so as to reduce the incidence rate of other diseases caused by hyperlipidemia.

Specifically, the inventors provide the following technical solutions:

a blood fat reducing herbal tea composition comprises wintersweet leaves, small black tea and cyclocarya paliurus, and is prepared from the following raw materials in parts by weight: 2-3 parts of wintersweet leaves, 2-3 parts of millet black tea and 1-2 parts of cyclocarya paliurus.

Preferably, the wintersweet leaves are derived from willow leaf wintersweet or leaves or tender shoots of Zhejiang wintersweet, and are processed according to the herbal tea recorded in 2015 edition Zhejiang Chinese medicine processing standard. Chimonanthus salicifolius S.Y. Hu is a semievergreen shrub in the family of Chimonanthus salicifolius, and the Chinese name is Chimonanthus salicifolius because the acronym aHicfolus in the Latin's name is the meaning of the leaf of the willow. In the Qiyunshan and Jiangxi posture sources in Anhui Huangshan city, one of the four major hallway religions in China, Chimonanthus salicifolius has been always called as "Xiangfeng tea", "Xiangfeng grass" or "shan Chimonanthus salicifolius", and is commonly seen in hillsides, open fields, stream ditch sides, secondary forests and forest margins. Tender shoots can be picked and processed from the middle ten days of 4 months to the last ten days of 5 months. Zhejiang wintersweet is called "light leaf wintersweet" in academic name, the leaves are relatively long, the branches and leaves are luxuriant, the four seasons are evergreen, the leaves are smaller than the wintersweet, but the wintersweet has thick fragrance.

The herbal tea is prepared from Chimonanthus salicifolius (Chimonanthus salicifolius S.Y.Hu) or Zhejiang wax plum (Chimonanthus zhejiangensis M.C.Liu) of Chimonanthus in Chimonanthus of Chimonanthus in 2015 by using the leaf as the raw material. In the embodiment of the invention, she medicine-food cold tea sold in the market is directly adopted. The edible herbal tea is prepared from Chimonanthus salicifolius S.Y.H and Ch.zhenjiangensist M.C.Liou of Chimonanthus salicifolius of Chimonanthus of Chimonadaceae, is a common tea beverage for she and countryside, mainly has the effects of relieving summer-heat, invigorating stomach, promoting digestion, diminishing inflammation and resisting viruses, has the effects of reducing fat, strengthening brain, losing weight and sobering up, and can enhance the immunity of human bodies. The determination shows that the herbal tea mainly contains eucalyptol, alkaloid, flavonoid, scyllo-inositol and other components, wherein VB1, VB2 and VC are rich in content, 18 amino acids necessary for human bodies are contained, the amino acid content is higher than that of any tea drink, and the herbal tea also contains trace elements necessary for human bodies, such as iron, zinc, calcium, magnesium, selenium and the like.

The invention discloses a novel red-mountain millet black tea, which is divided into a red-mountain millet and a wild millet, and preferably adopts the red-mountain millet black tea, the tea is thick red in liquor color after being soaked in water, the aroma is high and long, the fragrance is pine cigarette aroma, the taste is mellow, the tea has longan liquor flavor, and the organic tea of the red-mountain millet is produced in the national natural protection area of Wuyi mountain. Has effects of refreshing, benefiting intelligence, promoting urination, relaxing bowels, consolidating teeth, preventing dental caries, diminishing inflammation, sterilizing, removing toxic substance, relieving hangover, reducing blood lipid, lowering blood pressure, removing greasiness, resolving food stagnation, protecting liver, improving eyesight, preventing radiation, resisting canceration, resisting aging, and prolonging life.

Cyclocarya paliurus (Latin name: Cyclocaraya palaurus.) is also called as Cyclocarya paliurus: cyclocarya paliurus, salix caprae, and ashitaba tree. According to the records of the Chinese materia medica resource record, the cyclocarya paliurus leaves have the effects of clearing heat, quenching thirst and detoxifying.

The composition provided by the invention takes the leaves of the wintersweet of the herbal tea as the main component, is supplemented with the black tea of the small seed and the cyclocarya paliurus, has a synergistic effect, follows the meridian tropism principle of the traditional Chinese medicine, applies the effect of mutual coordination of the medicines, is reasonable in proportion, and has the cure rate of more than 90% and the effective rate of more than 97% through clinical verification.

The preparation method of the blood fat reducing herbal tea composition comprises the following steps:

the herbal tea is crushed, sieved (40 meshes), mixed with the small black tea and the cyclocarya paliurus, and then bagged, wherein each bag is filled with 2g of the mixture, and then the mixture is packaged in a sealed bag, boxed and boxed.

In the embodiment of the invention, the herbal tea, the small seed black tea and the cyclocarya paliurus are all commercially available products.

Compared with the prior art, the invention has the advantages that:

the blood fat reducing herbal tea composition provided by the invention has no toxic or side effect, has good effects of reducing triglyceride and cholesterol, and can improve the concentration of high-density lipoprotein, thereby reducing the incidence rate of other diseases caused by hyperlipidemia. In addition, the waxberry leaves are cold in nature, the taste can be adjusted by adding the small black tea and the cyclocarya paliurus, and the cold nature of the small black tea can be neutralized, so that the waxberry leaves are more easily accepted by people and are beneficial to more people.

Detailed Description

The present invention will be described in more detail with reference to examples.

In the invention, all parts and percentages are weight units, and all equipment, raw materials and the like can be purchased from the market or are commonly used in the industry, if not specified. The methods in the following examples are conventional in the art unless otherwise specified.

Example 1

The tea is prepared from 2 parts of herbal tea, 2 parts of Xiaozhong black tea and 1 part of cyclocarya paliurus.

Crushing the herbal tea, sieving with a 40-mesh sieve, mixing with the small black tea and cyclocarya paliurus, bagging at 2g per bag, sealing, and packaging to obtain the bagged tea.

Example 2

The tea is prepared from 3 parts of herbal tea, 2 parts of Xiaozhong black tea and 1 part of cyclocarya paliurus.

Crushing the herbal tea, sieving with a 40-mesh sieve, mixing with the small black tea and the cyclocarya paliurus, bagging 2g each bag, sealing and packaging.

Example 3

The tea is prepared from 3 parts of herbal tea, 3 parts of Xiaozhong black tea and 2 parts of cyclocarya paliurus.

Example 4

The tea is prepared from 2 parts of herbal tea, 3 parts of Xiaozhong black tea and 1 part of cyclocarya paliurus.

Example 5

The tea is prepared from 2 parts of herbal tea, 3 parts of Xiaozhong black tea and 2 parts of cyclocarya paliurus.

Example 6

The tea is prepared from 3 parts of herbal tea, 2 parts of Xiaozhong black tea and 2 parts of cyclocarya paliurus.

The teabag of any embodiment is taken for volunteers, the clinical display effect is not different, and the technical effect of the technical scheme of the invention is described by taking some typical examples below.

Application example

9 volunteers with high blood fat were collected and the effect test was carried out in three groups: wherein the first group is volunteers 1, 2 and 3, and symptoms are all frequent dizziness, headache, insomnia, hypodynamia and forgetting; the second group is volunteer 4, volunteer 5 and volunteer 6, all symptoms are frequent dizziness, and in severe cases, the patients can not stand by themselves, have chest distress, palpitation, disordered thinking and facial black spots; the third group was volunteer 7, volunteer 8 and volunteer 9, all of which were obese, often numb hands and feet, with a yellowish small rash on the eyelids.

Each group of volunteers took the tea bag according to the following method: the first stage takes some brand of red yeast rice, ginkgo leaf and red sage capsule sold in the market for 3 months, the second stage takes the finished product prepared in the embodiment 1 for 3 months, and the third stage takes the finished product prepared in the embodiment 6 for 3 months, wherein the dosage of each stage is 4 g/day/person, 2g each time, and the capsules are taken in the morning and evening respectively. The test results are as follows.

A suitable concentration of TG in normal plasma is 50-150mg/dl, a suitable concentration of TC is 110-220mg/dl, a suitable concentration of HDL is 35-85mg/dl, and a suitable concentration of LDL is 120mg/dl or less.

Volunteers 1, male, 44 years old, had plasma TC concentrations continuously above 270mg/dl, TG concentrations continuously above 350mg/dl, HDL concentrations continuously below 40mg/dl, and LDL concentrations above normal values prior to testing. After the first period, insomnia, forgetfulness, diarrhea symptoms occurred, and the plasma TC concentration was 205mg/dl, and the TC, HDL and LDL concentrations were normal. After the second stage, the insomnia is basically avoided, the body is vigorous, the head is not dizzy, the pain is relieved, after the third stage, the sleep quality is improved, the one-time sleep lasts for 8 hours, the body feels vigorous obviously, the head is not dizzy and painful, the memory is improved obviously, the concentrations of TG, TC, HDL and LDL in blood plasma are recovered to be normal, and the phenomena of diarrhea, flatulence and rash do not occur.

Volunteers 2, male, 32 years old, had plasma TC concentrations continuously above 340mg/dl, TG concentrations continuously above 300mg/dl, HDL concentrations continuously below 40mg/dl, and LDL concentrations continuously above 150mg/dl prior to testing. After the first stage, insomnia, hypodynamia and flatulence symptoms occur, the concentration of TG in plasma is 208mg/dl, the concentration of TC is 156mg/dl, and the concentrations of HDL and LDL are normal. In the second stage, the body is strong, the head is not dizzy and does not feel painful, and insomnia occasionally occurs; after the third stage, no insomnia occurs, the sleep quality is improved, the memory is improved obviously, the concentrations of TG, TC, HDL and LDL in blood plasma are all recovered to be normal, and the phenomena of diarrhea, flatulence and rash do not occur.

Volunteers 3, women, 53 years old, had plasma TC concentrations continuously above 400mg/dl, TG concentrations continuously above 280mg/dl, HDL concentrations continuously below 40mg/dl, and LDL concentrations continuously above 120mg/dl prior to testing. After the first stage, occasionally, the patient feels tired, is slightly dizzy, has flatulence symptoms, has the TG concentration of 212mg/dl in blood plasma and normal concentrations of TC, HDL and LDL; after the second stage, the head is not dizzy and painful, and the insomnia is not caused; after the third stage, the body is powerful, no insomnia occurs, the memory is obviously improved, the concentrations of TG, TC, HDL and LDL in blood plasma are all recovered to be normal, and the phenomena of diarrhea, flatulence and rash do not occur.

Volunteers 4, women, age 39, had plasma TC concentrations continuously above 310mg/dl, TG concentrations continuously above 230mg/dl, HDL concentrations continuously below 40mg/dl, and LDL concentrations continuously above 130mg/dl prior to testing. After the first stage, occasionally feeling of weakness, palpitation not relieved, dark spot still, TG concentration in plasma of 215mg/dl, TC concentration of 156mg/dl, HDL concentration of 35mg/dl, and LDL concentration normal; after the second stage, light dizziness, clear head and palpitation are weakened; after the third stage, the chest is smooth, the spirit is gained, the black spots are lightened, the number of the black spots is reduced, the concentrations of TG, TC, HDL and LDL in blood plasma are all recovered to be normal, and the phenomena of diarrhea, flatulence and rash do not occur.

Volunteers 5, women, 47 years old, had plasma TC concentrations continuously above 360mg/dl, TG concentrations continuously above 200mg/dl, HDL concentrations continuously below 40mg/dl, and LDL concentrations continuously above 180mg/dl prior to testing. After the first stage, dizziness, chest distress and basically unchanged amount of black spots occur, the concentration of TG in plasma is 210mg/dl, the concentration of TC is 152mg/dl, the concentration of HDL is 50mg/dl and the concentration of LDL is 128 mg/dl; after the second stage, dizziness occasionally occurred, the head and brain were clear, the chest was smooth, and dark spots were relieved; after the third stage, there is no palpitation, clear thought, the blood plasma has recovered the concentration of TG, TC, HDL and LDL, and there is no diarrhea, flatulence and rash.

Volunteers 6, male, 33 years old, had plasma TC concentrations continuously above 360mg/dl, TG concentrations continuously above 180mg/dl, HDL concentrations continuously below 40mg/dl, and LDL concentrations continuously above 120mg/dl prior to testing. After the first stage, dizziness, chest distress and more black spots occur, the concentration of TG and TC in blood plasma is higher than the normal value, and the concentration of LDL is lower than the normal value; after the second stage, dizziness occasionally occurred, the head was clear, and the chest was smooth; after the third stage, there is no palpitation, clear thought, and the concentrations of TG, TC, HDL and LDL in plasma are all recovered to normal without diarrhea, flatulence and rash.

Volunteers 7, women, age 49, had plasma TC concentrations continuously above 360mg/dl, TG concentrations continuously above 180mg/dl, HDL concentrations continuously below 40mg/dl, and LDL concentrations continuously above 120mg/dl prior to testing. After the first stage, hands and feet are numb frequently, the epithelial rash of the eyelid is still, the TG concentration and TC concentration in plasma are higher than normal values, and the HDL concentration is lower than normal values; after the second stage, the hands and feet are numb, and the number of rashes on the eyelids is reduced; after the third stage, the rash on the eyelid subsides, the hands and feet are not numb basically, the concentrations of TG, TC, HDL and LDL in the blood plasma are all recovered to be normal, and the phenomena of diarrhea, flatulence and rash do not appear.

Volunteers 8, male, 53 years old, had plasma TC concentrations continuously above 315mg/dl, TG concentrations continuously above 190mg/dl, HDL concentrations continuously below 40mg/dl, and LDL concentrations continuously below 120mg/dl prior to testing. After the first phase, often numbness in the hands and feet, plasma TG and TC concentrations are higher than normal, and HDL concentrations are lower than normal. LDL concentrations were higher than normal. After the second stage, the hands and feet are numb, and the rash on the eyelid is lightened; after the third stage, the rash on the eyelid subsides, the hands and feet are not numb basically, the concentrations of TG, TC, HDL and LDL in the blood plasma are all recovered to be normal, and the phenomena of diarrhea, flatulence and rash do not appear.

Volunteers 9, women, 43 years old, had plasma TC concentrations consistently above 315mg/dl, TG concentrations consistently above 200mg/dl, HDL concentrations consistently below 40mg/dl, and LDL concentrations consistently above 120mg/dl prior to testing. After the first phase, the hands and feet are often numb, there is a small number of rashes on the eyelids, TG and TC concentrations in the plasma are higher than normal, HDL concentrations are lower than normal, and LDL concentrations are higher than normal. After the second stage, the hands and feet are numb, and the rash on the eyelid is lightened; after the third stage, the rash on the eyelid subsides, the hands and feet are not numb basically, the concentrations of TG, TC, HDL and LDL in the blood plasma are all recovered to be normal, and the phenomena of diarrhea, flatulence and rash do not appear.

In conclusion, the hypolipidemic teabag prepared by the invention has a good hypolipidemic effect on people with hyperlipidemia, and has no side effect caused by taking western medicines.

Finally, it should be noted that the above embodiments are merely representative examples of the present invention. Obviously, the technical solution of the present invention is not limited to the above-described embodiments, and many variations are possible. All modifications which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims

1. The blood fat reducing herbal tea composition is characterized by consisting of wintersweet leaves, small black tea and cyclocarya paliurus, and comprises the following components in parts by weight: 2-3 parts of wintersweet leaves, 2-3 parts of millet black tea and 1-2 parts of cyclocarya paliurus.

2. The diet herbal tea composition for reducing blood lipid according to claim 1, wherein the wintersweet leaves are derived from leaves or tender shoots of willow leaf wintersweet or Zhejiang wintersweet, and are used after being processed.

3. The blood lipid reducing herbal tea composition of claim 1, wherein the kokuchia scoparia black tea is a chokuchia japonica black tea.

4. The blood lipid reducing herbal tea composition of claim 1, wherein the blood lipid reducing herbal tea composition is prepared by the following method: the wintersweet leaves are crushed, sieved, mixed with the small black tea and the cyclocarya paliurus, and bagged, wherein each bag is 2 g.